首页> 美国卫生研究院文献>The Korean Journal of Pain >Stem cell therapy in pain medicine
【2h】

Stem cell therapy in pain medicine

机译:止痛药中的干细胞疗法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Stem cells are attracting attention as a key element in future medicine, satisfying the desire to live a healthier life with the possibility that they can regenerate tissue damaged or degenerated by disease or aging. Stem cells are defined as undifferentiated cells that have the ability to replicate and differentiate themselves into various tissues cells. Stem cells, commonly encountered in clinical or preclinical stages, are largely classified into embryonic, adult, and induced pluripotent stem cells. Recently, stem cell transplantation has been frequently applied to the treatment of pain as an alternative or promising approach for the treatment of severe osteoarthritis, neuropathic pain, and intractable musculoskeletal pain which do not respond to conventional medicine. The main idea of applying stem cells to neuropathic pain is based on the ability of stem cells to release neurotrophic factors, along with providing a cellular source for replacing the injured neural cells, making them ideal candidates for modulating and possibly reversing intractable neuropathic pain. Even though various differentiation capacities of stem cells are reported, there is not enough knowledge and technique to control the differentiation into desired tissues in vivo. Even though the use of stem cells is still in the very early stages of clinical use and raises complicated ethical problems, the future of stem cells therapies is very bright with the help of accumulating evidence and technology.
机译:干细胞作为未来医学中的关键要素吸引了人们的注意,它满足了人们过健康生活的愿望,并有可能使它们再生出因疾病或衰老而受损或退化的组织。干细胞定义为未分化的细胞,具有将自身复制和分化为各种组织细胞的能力。在临床或临床前阶段通常遇到的干细胞主要分为胚胎干细胞,成年干细胞和诱导性多能干细胞。近来,干细胞移植已被广泛地用于治疗疼痛,作为治疗对传统药物无反应的严重骨关节炎,神经性疼痛和顽固性肌肉骨骼疼痛的替代方法或有希望的方法。将干细胞应用于神经性疼痛的主要思想是基于干细胞释放神经营养因子的能力,以及为替换受损神经细胞提供细胞来源,使其成为调节和逆转顽固性神经性疼痛的理想人选。即使报道了干细胞的各种分化能力,但是仍然没有足够的知识和技术来控制体内分化成所需组织的能力。尽管干细胞的使用仍处于临床使用的早期阶段,并引发了复杂的伦理问题,但在不断积累的证据和技术的帮助下,干细胞疗法的未来非常光明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号